<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2022 (5) TMI 1668 - Supreme Court</title>
    <link>https://www.taxtmi.com/caselaws?id=460641</link>
    <description>A vaccination policy affecting fundamental rights is subject to judicial review for legality, reasonableness and manifest arbitrariness, even though courts generally defer to executive and expert public-health judgment. Bodily integrity and personal autonomy under Article 21 mean vaccination cannot be physically compelled, and restrictions on unvaccinated persons must satisfy a legitimate public health aim and proportionality. The text also states that trial results and required future data should be published under the clinical-trial framework, but segregated primary trial data need not be disclosed absent a legal mandate. It further notes that adverse-event reporting systems should permit wider self-reporting and that paediatric vaccination policy is ordinarily left to expert consensus.</description>
    <language>en-us</language>
    <pubDate>Mon, 02 May 2022 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 07 Feb 2025 12:49:05 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=796146" rel="self" type="application/rss+xml"/>
    <item>
      <title>2022 (5) TMI 1668 - Supreme Court</title>
      <link>https://www.taxtmi.com/caselaws?id=460641</link>
      <description>A vaccination policy affecting fundamental rights is subject to judicial review for legality, reasonableness and manifest arbitrariness, even though courts generally defer to executive and expert public-health judgment. Bodily integrity and personal autonomy under Article 21 mean vaccination cannot be physically compelled, and restrictions on unvaccinated persons must satisfy a legitimate public health aim and proportionality. The text also states that trial results and required future data should be published under the clinical-trial framework, but segregated primary trial data need not be disclosed absent a legal mandate. It further notes that adverse-event reporting systems should permit wider self-reporting and that paediatric vaccination policy is ordinarily left to expert consensus.</description>
      <category>Case-Laws</category>
      <law>Indian Laws</law>
      <pubDate>Mon, 02 May 2022 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=460641</guid>
    </item>
  </channel>
</rss>